Drugs / MenAC conjugate vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07135986 Comparator | Sep 2025 → May 2026 overdue | meningococcal infection | Sanofi | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MenAC conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07135986 ↗ |